Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse

IMPORTANCE: The optimal treatment approach to patients with acute myeloid leukemia (AML) who relapse after an allogeneic hematopoietic cell transplant (allo-HCT) remains elusive. No randomized clinical trial comparing survival outcomes of a second allo-HCT (allo-HCT2) vs donor lymphocyte infusion (D...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Kharfan-Dabaja, Mohamed A., Labopin, Myriam, Polge, Emmanuelle, Nishihori, Taiga, Bazarbachi, Ali, Finke, Jürgen, Stadler, Michael, Ehninger, Gerhard, Lioure, Bruno, Schaap, Nicolaas, Afanasyev, Boris, Yeshurun, Moshe, Isaksson, Cecilia, Maertens, Johan, Chalandon, Yves, Schmid, Christoph, Nagler, Arnon, Mohty, Mohamad
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2018
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143013/
https://ncbi.nlm.nih.gov/pubmed/30003233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2018.2091
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados